Natera, Inc. is a leading global provider of genetic testing and diagnostics, specializing in non-invasive prenatal testing (NIPT), oncology, and organ transplantation. The company leverages advanced cell-free DNA technology to deliver accurate and reliable genetic insights, helping patients and healthcare providers make informed decisions. Natera’s flagship product, Panorama, is a widely recognized non-invasive prenatal test […]
Read MoreGeneDx Holdings Corp. is a leading genetics and genomics testing company that specializes in providing advanced diagnostic solutions to identify and understand genetic disorders. The company offers a wide range of genetic testing services, including whole exome sequencing, whole genome sequencing, and targeted gene panels. These services are crucial for diagnosing rare genetic diseases, guiding […]
Read MoreFulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. FLGT $88.8200 3.3900 % 3.9700 […]
Read More